Low Density Lipoprotein (LDL) Cholesterol as a Causal Role for Atherosclerotic Disease: Potential Role of PCSK9 Inhibitors. [electronic resource]
Producer: 20190723Description: 199-207 p. digitalISSN:- 1179-1985
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents -- adverse effects
- Atherosclerosis -- blood
- Biomarkers -- blood
- Cholesterol, LDL -- blood
- Dyslipidemias -- blood
- Humans
- PCSK9 Inhibitors
- Practice Guidelines as Topic
- Proprotein Convertase 9 -- metabolism
- Risk Factors
- Serine Proteinase Inhibitors -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.